Ethical Compliance
ALBERT DAVID
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
12.5%
Debt
0.4%
Liquidity
6.3%
Revenue
Debt
Liquidity
12.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals | ₹360.26 |
| Scrap sales | ₹1.74 |
| Export incentives | ₹0.45 |
| Other Income | ₹0.06 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹47.52 |
Non Compliant
INR Crores
| Interest income | ₹4.07 |
INR Crores
| Revenue from Questionable Sources: | ₹47.52 |
| Revenue from Non Compliant Sources: | ₹4.07 |
| Total: | ₹51.60 |
| Total Revenue: | ₹414.12 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹51.60
₹414.12
= 12.5%
non-compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
